Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Hospital Sagrado Corazón
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Sagrado Corazón (7)
2024
-
Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort
Critical Care, Vol. 28, Núm. 1
2023
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997
2022
-
One-year mortality after ICU admission due to COVID-19 infection
Intensive Care Medicine
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2004
-
Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer
Clinical Breast Cancer, Vol. 5, Núm. 2, pp. 131-135
-
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: Results of a large, multicentre phase II study
Cancer Chemotherapy and Pharmacology, Vol. 53, Núm. 1, pp. 75-81